Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Neumann

Showing results (321-330 of 404) with videos related to

Pageof 41
Sort By:
Scandinavian Journal of Gastroenterology|October 22, 2008
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infectionJohan Westin, Magdalena Ydreborg, Sara Islam, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replicationMagali Bouvier-Alias, Keyur Patel, Harel Dahari, et al.
Transplantation Proceedings|September 2, 1998
Incidence and risk factors of prolonged mechanical ventilation and causes of reintubation after liver transplantationM Glanemann, J M Langrehr, A R Müller, et al.
Science (New York, N.Y.)|April 26, 1996
Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infectionS M Wolinsky, B T Korber, A U Neumann, et al.
Nanomaterials (Basel, Switzerland)|September 30, 2017
Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface ModificationFrancesca Alessandrini, Antje Vennemann, Silvia Gschwendtner, et al.
Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.
Transplantation Proceedings|March 20, 1999
The effect of cyclosporine vs FK 506 on glucose metabolismT Steinmueller, T Konrad, S Jonas, et al.
HIV Clinical Trials|August 9, 2013
Baseline CD4+ T-cell counts predict HBV viral kinetics to adefovir treatment in lamivudine-resistant HBV-infected patients with or without HIV infectionK J Cortez, M A Proschan, L Barrett, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2012
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis CStéphanie Pascarella, Sophie Clément, Michael T Dill, et al.
World Journal of Gastroenterology|December 5, 2006
Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapyJose-Eymard Medeiros-Filho, Isabel-Maria-Vicente-Guedes de Carvalho Mello, Joao-Renato-Rebello Pinho, et al.
Pageof 41

Showing results (321-330 of 404) with videos related to

Sort By:
Pageof 41
Scandinavian Journal of Gastroenterology|October 22, 2008
A non-invasive fibrosis score predicts treatment outcome in chronic hepatitis C virus infectionJohan Westin, Magdalena Ydreborg, Sara Islam, et al.
Hepatology (Baltimore, Md.)|June 27, 2002
Clinical utility of total HCV core antigen quantification: a new indirect marker of HCV replicationMagali Bouvier-Alias, Keyur Patel, Harel Dahari, et al.
Transplantation Proceedings|September 2, 1998
Incidence and risk factors of prolonged mechanical ventilation and causes of reintubation after liver transplantationM Glanemann, J M Langrehr, A R Müller, et al.
Science (New York, N.Y.)|April 26, 1996
Adaptive evolution of human immunodeficiency virus-type 1 during the natural course of infectionS M Wolinsky, B T Korber, A U Neumann, et al.
Nanomaterials (Basel, Switzerland)|September 30, 2017
Pro-Inflammatory versus Immunomodulatory Effects of Silver Nanoparticles in the Lung: The Critical Role of Dose, Size and Surface ModificationFrancesca Alessandrini, Antje Vennemann, Silvia Gschwendtner, et al.
Journal of Hepatology|March 1, 2011
IL28B polymorphisms predict reduction of HCV RNA from the first day of therapy in chronic hepatitis CP-Y Bochud, S Bibert, F Negro, et al.
Transplantation Proceedings|March 20, 1999
The effect of cyclosporine vs FK 506 on glucose metabolismT Steinmueller, T Konrad, S Jonas, et al.
HIV Clinical Trials|August 9, 2013
Baseline CD4+ T-cell counts predict HBV viral kinetics to adefovir treatment in lamivudine-resistant HBV-infected patients with or without HIV infectionK J Cortez, M A Proschan, L Barrett, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 21, 2012
Intrahepatic mRNA levels of SOCS1 and SOCS3 are associated with cirrhosis but do not predict virological response to therapy in chronic hepatitis CStéphanie Pascarella, Sophie Clément, Michael T Dill, et al.
World Journal of Gastroenterology|December 5, 2006
Differences in viral kinetics between genotypes 1 and 3 of hepatitis C virus and between cirrhotic and non-cirrhotic patients during antiviral therapyJose-Eymard Medeiros-Filho, Isabel-Maria-Vicente-Guedes de Carvalho Mello, Joao-Renato-Rebello Pinho, et al.
Pageof 41